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Abstract
Plasmacytoma are extramedullary accumulations of plasma cells. Most extramedullary
Plasmacytomas are associated with the upper respiratory tract. The mediastinum is rarely
involved. We report a rare case of mediastinal plasmacytoma with multiple myeloma. The patient
is 66 year old woman presented with bone pains and mediastinal mass on CT scan and MRI. The
preliminary diagnosis of occult lung cancer with mediastinal involvement, and widespread skeletal
metastasis was made, although lymphoproliferative disorder along with germ cell tumor was also
kept in differentials.
The diagnosis of mediastinal plasmacytoma with multiple myeloma was made after extensive
investigations
Introduction
Plasmacytoma, a neoplastic proliferation of plasma cells,
is a form of plasma cell dyscrasia that may manifest as
multiple myeloma, primary amyloidosis, or monoclonal
gammopathy of unknown significance. Plasmacytoma
may be primary or secondary to disseminated multiple
myeloma and may arise from osseous (medullary) or
nonosseous (extramedullary) sites. Primary extramedul-
lary plasmacytoma can be solitary or multiple [1]. The
mediastinum is rarely involved by extramedullary plas-
macytoma. We report a case of mediastinal plasmacytoma
with multiple myeloma which is extremely rare in clinical
practice. Our case highlights mediastinal plasmacytoma
as differential diagnosis for mediastinal masses and
aggressive search for multiple myeloma.
Case presentation
A 66 year old lady referred to our oncology clinic for the
management of mediastinal mass. Two weeks prior to her
visit, she started with severe low back pain radiating to
lower extremities, nausea, retching, and mild dyspnea.
She was admitted in the hospital, thorough investigation
revealed mediastinal mass on CT scan (Figure 1). MRI of
spine showed L4–L5 disc herniation along with signifi-
cant spinal canal stenosis. She received treatment and was
discharged in stable condition after 5 days of admission.
The patient's history was significant for GERD, Oste-
oporosis, and Hypercholestemia. She has been smoking
less than a pack a day for 40 years and quit a month ago.
Family history was remarkable for lung cancer (In her
father, who died at the age 76) and sarcoidosis (in her
only daughter). Current medications include rosuvasta-
tin, omeprazole, Ibandronate, and ibuprofen.
On her first visit to our clinic, the patient was little uncom-
fortable due to bone pains, her blood pressure was 104/
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60 mmHg, heart rate of 84 beats per minute, respiratory
rate 12 breathes per minute, and body temperature 99.6 F.
The cardiac and lung examination showed no murmurs,
gallops, wheeze or rhonci. The rest of the examination
which included HEENT, neck, abdomen, lymph nodes,
and musculoskeletal was unremarkable.
The MRI showed 3.9 × 4.2 cms mass in azygoesophageal
recess, the pathologic fracture of 8th right rib, abnormal
bone marrow signal in multiple areas of right sacroiliac
joint, left superior acetabulum, and right greater tro-
chanter. The PET scan confirmed these findings with
uptake in all of these regions (Figure 2).
The provisional diagnosis of occult lung cancer with
mediastinal involvement and wide spread skeletal metas-
tasis was made, although the diagnosis of lymphoprolifer-
ative disorder and germ cell tumor was kept in
differentials.
The patient underwent biopsy of mediastinal mass, which
was found to be consistent with plasmacytoma (lambda
light chain restricted). A bone marrow examination
showed marrow involvement by plasma cell neoplasm
(Overall 10% of the total cellularity). Figure 3, 4, and 5
Laboratory studies showed normochromic anemia
(Hemoglobin level 107 g/l, MCV 86 fl), elevated ESR (61
mm/hr) and normal white cell and blood count. Beta
microglobulin was elevated (5.2 mg/L) and BUN/Creati-
nine (21/1.3) was normal. Serum protein electrophoresis
and immunofixation electrophoresis were negative but 24
hours urine for protein electrophoresis and immunofixa-
tion electrophoresis were consistent with free lambda
chain measuring 85 mg/dl.
CT scan of chest showing mediastinal mass and pathological  fracture of the right 8th rib Figure 1
CT scan of chest showing mediastinal mass and path-
ological fracture of the right 8th rib.
PET scan showing hypermetabolic activity in azygoesophageal  recess and right 8th rib Figure 2
PET scan showing hypermetabolic activity in azy-
goesophageal recess and right 8th rib.
H&E stain illustrating trilineage hematopoiesis Figure 3
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Further workup included a cytogenetic/FISH analysis
(showed abnormal result for chromosome 14, consistent
with the presence of clonal lymphoid hematologic malig-
nancy) Figure 6. Flow cytometry detected CD 56 + mono-
clonal plasma cells (1% of nucleated cells) also consistent
with plasma cell disorder. The diagnosis of indolent mul-
tiple myeloma was made. The patient was put on chemo-
therapy with bortezomib and dexamethasone and is
planned for autologous stem cell transplant (ASCT).
Discussion
Extramedullary plasmacytoma (EMP) is a rare plasma cell
neoplasm of the soft tissue and constitutes about 4% of all
plasma cell tumors [2]. The most common site for
extramedullary involvement is the upper aerodigestive
tract [3]. The mediastinum is rarely involved by extramed-
ullary plasmacytoma [3]. Only 5% of patients with EMP's
have coexistent multiple myeloma [4]. However, in our
case, a diagnosis of multiple myeloma was established
within a month after the diagnosis of the mediastinal
mass.
The sequences of proceedings suggest that the mediastinal
plasmacytoma provided an early hint to the diagnosis of
multiple myeloma, and therefore we conclude that the
multiple myeloma was coexisting with the mediastinal
lesion [5]. Our case is unique in the sense mediastinal
plasmacytoma with multiple myeloma presenting simul-
taneously is extremely rare. The plasmacytoma in our case
is aggressive revealed by the enhancer uptake on PET scan
in distinction to the lack of increased uptake in indolent
plasmacytoma [6,7]. Another aspect of our case is that it
presented like a diagnostic dilemma; we initially thought
that the diagnosis of occult lung cancer with mediastinal
involvement with widespread skeletal metastasis. How-
ever, diagnosis of plasmacytoma with multiple myeloma
was reached after extensive investigations.
After diagnosis of plasmacytoma aggressive search for
multiple myeloma is vital as the management is entirely
different for both types of Plasma Cell Dyscrasias
Plasmacytomas are treated with radiotherapy, surgery or
both [8]. Chemotherapy may be considered for patients
with refractory or relapsed disease [8] whereas multiple
myeloma is mostly treated with chemotherapy [9].
Extranodal plasmacytoma in a patient with multiple mye-
loma carries a poor prognosis and treatment, which
includes chemotherapy or autologous hematopoietic cell
transplantation which is directed towards the underlying
CD138 stain demonstrating increased plasma cells Figure 4
CD138 stain demonstrating increased plasma cells.
Plasma cells show excess lambda chain expression Figure 5
Plasma cells show excess lambda chain expression.
FISH showing abnormal result for chromosome 14 consist- ent with multiple myeloma Figure 6
FISH showing abnormal result for chromosome 14 
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disease [10]. Our case also demonstrates the clinical use-
fulness of PET/CT scan in imaging plasmacytoma [6].
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